Sjögren's disease: open trials in Canada

• NCT07737743

  A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

  Trial Treatment · Phase 2 · Novartis Pharmaceuticals

  Rimouski · Sherbrooke · Trois-Rivières

  Registry updated 2026-10-28

• NCT07621809

  Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Rimouski · Sherbrooke · Sydney

  Registry updated 2026-10-13

• NCT03816345

  Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  Trial Treatment · Phase 1 · National Cancer Institute (NCI)

  University Health Network, Princess Margaret Hospital, Toronto

  Registry updated 2026-10-05

• NCT06747949

  A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

  Trial Treatment · Phase 3 · Amgen

  Clinique de Rhumatologie Du Centre Du Quebec, Trois-Rivières

  Registry updated 2026-04-28

All Sjögren's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error